Skip to main content

Find Clinical Trials

Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,152 public trials 551 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

NCT01359917

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
Locations: Not specified

View Trial Details

Completed

TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options

NCT00115050

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers

NCT01371175

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: KAVI (Kenya AIDS Vaccine Initiative) Nairobi, Kenya

Guys and St. Thomas' Hospital London, United Kingdom

View Trial Details

Completed

Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients

NCT00904384

Conditions: Blood-Borne Infections, COPD, Chronic Disease, +21 more
Locations: Hospital Universitario Son Dureta Palma de Mallorca, Balearic Islands, Spain

View Trial Details

Completed

Chiron Corp HCV E1/E2 Vaccine

NCT00500747

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Saint Louis University St Louis, Missouri, United States

View Trial Details

Completed

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

NCT00503347

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
Locations: Impact Clinical Research Los Angeles, California, United States

Orange Coast Medical Center Newport Beach, California, United States

AIDS Research Consortium of Atlanta Atlanta, Georgia, United States

Johns Hopkins University, Center for Viral Hepatitis Baltimore, Maryland, United States

View Trial Details

Completed

TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation

NCT00812292

Conditions: Bioavailability, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

NCT00740389

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +18 more
Locations: Not specified

View Trial Details

Completed

TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.

NCT00744887

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Not specified

View Trial Details

Completed

TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.

NCT00828815

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Not specified

View Trial Details